Several other institutional investors have also recently added to or reduced their stakes in the company. United Services Automobile Association raised its holdings in Nu Skin Enterprises by 2.0% during the fourth quarter. United Services Automobile Association now owns 14,448 shares of the company’s stock worth $886,000 after acquiring an additional 277 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Nu Skin Enterprises by 3.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,132,318 shares of the company’s stock worth $69,442,000 after acquiring an additional 38,282 shares in the last quarter. Geode Capital Management LLC raised its holdings in Nu Skin Enterprises by 7.3% during the fourth quarter. Geode Capital Management LLC now owns 547,265 shares of the company’s stock worth $33,563,000 after acquiring an additional 37,229 shares in the last quarter. Bank of America Corp DE raised its holdings in Nu Skin Enterprises by 19.0% during the fourth quarter. Bank of America Corp DE now owns 79,310 shares of the company’s stock worth $4,863,000 after acquiring an additional 12,667 shares in the last quarter. Finally, Municipal Employees Retirement System of Michigan bought a new stake in Nu Skin Enterprises during the fourth quarter worth about $819,000. Hedge funds and other institutional investors own 77.35% of the company’s stock.
NYSE NUS traded up $1.10 during trading on Friday, reaching $40.37. 432,600 shares of the company’s stock were exchanged, compared to its average volume of 710,774. Nu Skin Enterprises, Inc. has a fifty-two week low of $35.03 and a fifty-two week high of $85.75. The business has a 50 day moving average price of $42.55 and a 200-day moving average price of $51.42. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.90 and a quick ratio of 1.20. The stock has a market capitalization of $2.20 billion, a P/E ratio of 11.47, a PEG ratio of 1.09 and a beta of 0.67.
Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Tuesday, August 6th. The company reported $0.83 EPS for the quarter, meeting the consensus estimate of $0.83. Nu Skin Enterprises had a return on equity of 24.73% and a net margin of 4.79%. The company had revenue of $623.50 million for the quarter, compared to the consensus estimate of $622.32 million. During the same quarter in the prior year, the business earned $0.95 earnings per share. The firm’s revenue for the quarter was down 11.5% on a year-over-year basis. On average, analysts forecast that Nu Skin Enterprises, Inc. will post 3.26 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 11th. Stockholders of record on Friday, August 30th will be given a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 3.67%. The ex-dividend date is Thursday, August 29th. Nu Skin Enterprises’s payout ratio is 42.05%.
Several analysts recently issued reports on the company. Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating in a report on Friday, May 3rd. Bank of America reissued an “underperform” rating and set a $52.00 price target (down previously from $57.00) on shares of Nu Skin Enterprises in a research report on Wednesday, June 19th. ValuEngine raised Nu Skin Enterprises from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 1st. Stifel Nicolaus set a $39.00 price target on Nu Skin Enterprises and gave the stock a “sell” rating in a research report on Wednesday, August 7th. Finally, Pivotal Research reissued a “buy” rating and set a $70.00 price target on shares of Nu Skin Enterprises in a research report on Wednesday, August 7th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. Nu Skin Enterprises presently has a consensus rating of “Hold” and an average price target of $53.25.
Nu Skin Enterprises Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Featured Article: Buyback
Receive News & Ratings for Nu Skin Enterprises Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s FREE daily email newsletter.